List of largest biomedical companies by revenue

Last updated

The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) that have generated a revenue of at least US$10 billion, ranked by their revenue in the respective financial year.

Contents

It does not include biotechnology companies that are now owned by, or form a part of, larger pharmaceutical groups.

Ranking by revenue

The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa. Green cells indicate years where revenue increased compared to the preceding year. Red cells indicate those years when there has been a decrease.

Largest biotechnology and pharmaceutical companies ranked by revenue in billion USD.
RankChgCompanyCountryTraded on2024202320222021202020192018201720162015
1Steady2.svg Johnson & Johnson Flag of the United States.svg  USA NYSE :  JNJ 88.82 [1] 85.16 [2] 79.99 [2] 93.78 [3] 82.59 [3] 82.06 [4] 81.60 [5] 76.50 [6] 71.89 [7] 70.10 [8]
2Steady2.svg Sinopharm Flag of the People's Republic of China.svg  CHN SEHK :  1099 84.06 [9] 80.19 [10] 75.68 [10] 71.75 [11] 60.18 [12] 48.75 [13] 43.63 [14] 36.56 [15] 32.36 [16]
3Steady2.svg Roche Flag of Switzerland (Pantone).svg  SUI SIX :  ROG 66.42 [17] 68.48 [18] 69.77 [19] 67.83 [20] 62.99 [20] 63.85 [21] 56.86 [22] 57.37 [23] 50.11 [24] 47.70 [25]
4Steady2.svg Merck & Co. Flag of the United States.svg  USA NYSE :  MRK 64.17 [26] 60.12 [27] 59.28 [28] 48.70 [29] 41.52 [29] 46.84 [30] 42.30 [31] 40.10 [32] 39.80 [33] 39.50 [34]
5Steady2.svg Pfizer Flag of the United States.svg  USA NYSE :  PFE 63.63 [35] 59.55 [35] 100.33 [36] 81.29 [37] 41.91 [38] 41.17 [38] 40.83 [38] 52.54 [39] 52.82 [40] 48.85 [41]
6Steady2.svg AbbVie Flag of the United States.svg  USA NYSE :  ABBV 56.33 [42] 54.32 [43] 58.05 [44] 56.20 [45] 45.80 [45] 33.27 [46] 32.75 [47] 28.22 [48] 25.56 [49] 22.82 [50]
7Steady2.svg Bayer Flag of Germany.svg  GER FWB :  BAYN 51.72 [51] 53.88 [52] 49.46 [53] 47.40 [54] 48.02 [55] 45.06 [56] 37.94 [57] 25.27 [58] 24.09 [59]
8Increase2.svg 1 AstraZeneca Flag of the United Kingdom.svg  GBR
Flag of Sweden.svg  SWE 		LSE :  AZN 54.07 [60] 45.81 [61] 44.35 [62] 37.42 [63] 26.62 [64] 24.38 [65] 22.09 [66] 22.47 [67] 23.00 [68] 24.71 [69]
9Increase2.svg 1 Novartis Flag of Switzerland (Pantone).svg  SUI NYSE :  NVS 50.32 [70] 45.44 [71] 50.55 [72] 51.63 [73] 48.66 [73] 47.45 [74] 44.75 [75] 49.11 [76] 48.52 [77] 49.41 [78]
10Increase2.svg 1 Bristol Myers Squibb Flag of the United States.svg  USA Nasdaq :  BMY 48.30 [79] 45.01 [80] 46.16 [81] 46.39 [82] 42.52 [82] 26.15 [83] 22.56 [84] 20.80 [85] 19.43 [86] 16.56 [87]
11Increase2.svg 4 Eli Lilly & Co Flag of the United States.svg  USA NYSE :  LLY 45.03 [88] 34.12 [89] 28.54 [90] 28.32 [91] 24.54 [92] 22.32 [93] 21.49 [94] 22.90 [95] 21.22 [96] 20.00 [97]
12Decrease2.svg 4 Sanofi Flag of France.svg  FRA NYSE :  SNY 42.68 [98] 46.84 [99] 46.86 [100] 43.24 [101] 41.27 [102] 39.28 [103] 39.07 [104] 42.91 [105] 36.57 [106] 36.73 [107]
13Decrease2.svg 1 Abbott Laboratories Flag of the United States.svg  USA Nasdaq :  ABT 41.95 [108] 40.11 [109] 43.65 [110] 43.08 [111] 34.61 [112] 31.90 [113] 30.60 [114] 27.39 [115] 20.85 [116] 20.41 [117]
14Increase2.svg 2 Novo Nordisk Flag of Denmark.svg  DEN NYSE :  NVO 40.52 [118] 33.83 [119] 25.46 [120] 21.66 [121] 19.52 [121] 18.30 [122] 6.99 [123] 18.77 [124] 16.61 [125] 16.06 [126]
15Decrease2.svg 2 GlaxoSmithKline Flag of the United Kingdom.svg  GBR LSE :  GSK 39.28 [127] 38.63 [128] 36.14 [129] 46.91 [130] 46.17 [131] 43.92 [132] 43.14 [133] 42.05 [134] 34.79 [135] 29.84 [136]
16Decrease2.svg 2 Shanghai Pharmaceuticals Flag of the People's Republic of China.svg  CHN SSE : 601607 36.68 [137] 32.33 [138] 31.82 [139] 29.29 [139] 27.50 [139] 23.45 [139] 19.28 [139] 17.80 [140] 15.55 [140]
17Steady2.svg Takeda Pharmaceutical Flag of Japan.svg  JPN TYO : 4502 30.24 [141] 30.34 [142] 29.31 [143] 27.76 [144] 31.17 [145] 19.10 [146] 16.70 [147] 15.96 [148] 14.93
18Steady2.svg Amgen Flag of the United States.svg  USA Nasdaq :  AMGN 33.42 [149] 28.19 [150] 26.32 [151] 25.98 [152] 25.42 [153] 23.40 [154] 23.70 [155] 22.80 [156] 22.99 [157] 21.66 [158]
19Steady2.svg Boehringer Ingelheim Flag of Germany.svg  GER Private27.70 [159] 25.90 [160] 22.50 [161] 22.40 [162] 21.75 [163] 21.67 [164] 17.54 [165] 16.41 [165] 17.70 [165]
20Steady2.svg Gilead Sciences Flag of the United States.svg  USA Nasdaq :  GILD 28.75 [166] 27.12 [167] 27.28 [168] 27.31 [168] 24.69 [169] 22.45 [170] 22.13 [171] 25.70 [172] 30.39 [172] 32.15 [172]
21Steady2.svg Siemens Healthineers Flag of Germany.svg  GER FWB :  SHL 23.21 [173] 23.32 [174] 23.09 [175] 20.61 [176] 16.56 [176] 16.62 [177] 15.37 [178] 16.56 [179] 14.25 [179] 14.06 [179]
22Steady2.svg Merck Group Flag of Germany.svg  GER ETR: MRK 22.79 [180] 23.64 [181] 21.40 [182] 20.08 [183] 18.25 [184] 16.48 [185] 18.70 [186] 16.62 [187] 14.25 [188]
23Steady2.svg Jointown Pharmaceutical Flag of the People's Republic of China.svg  CHN SSE : 600998 21.15 [189] 19.81 [190] 18.04 [191] 16.34 [192] 14.67 [193] 12.85 [194] 10.90 [195] 9.07 [196] 7.31 [197]
24Steady2.svg GE Healthcare Flag of the United States.svg  USA Nasdaq :  GEHC 19.67 [198] 19.55 [199] 18.34 [200] 17.73 [201] 18.01 [202] 19.94 [203] 19.78 [203] 19.02 [203] 18.21 [203] 17.64 [203]
25Steady2.svg Teva Pharmaceuticals Flag of Israel.svg  ISR Nasdaq :  TEVA 16.54 [204] 15.85 [205] 14.93 [206] 15.88 [207] 16.66 [208] 16.89 [209] 18.90 [210] 22.40 [211] 21.90 [212] 20.00 [213]
26Steady2.svg Kenvue Flag of the United States.svg  USA NYSE :  KVUE 15.46 [214] 15.44 [215] 14.95 [215]
27Steady2.svg Viatris Flag of the United States.svg  USA Nasdaq :  VTRS 14.69 [216] 15.43 [217] 16.22 [218] 17.81 [218] 11.95 [219]
28Increase2.svg 3 Regeneron Pharmaceuticals Flag of the United States.svg  USA Nasdaq :  REGN 14.20 [220] 13.12 [221] 12.17 [222] 16.07 [223] 8.50 [223] 7.86 [224] 6.71 [224] 5.87 [224] 4.86 [225] 4.10 [226]
29Steady2.svg Haleon Flag of the United Kingdom.svg  GBR LSE :  HLN 14.15 [227] 14.29 [228] 13.14 [229] 11.77 [230]
30Steady2.svg Otsuka Holdings Flag of Japan.svg  JPN TYO : 4578 14.23 [231] 13.05 [232] 11.65 [233] 11.06 [233] 10.85 [233] 10.04 [233] 9.64 [233] 9.29 [233] 11.10 [233]
31Increase2.svg 3 Vertex Pharmaceuticals Flag of the United States.svg  USA Nasdaq :  VRTX 11.02 [234] 9.87 [235] 8.93 [236] 7.57 [237] 6.20 [238] 4.16 [239] 3.04 [240] 2.16 [241] 1.68 [242] 1.03 [243]
32Decrease2.svg 4 Baxter International Flag of the United States.svg  USA NYSE :  BAX 10.64 [244] 14.81 [245] 15.11 [246] 12.78 [247] 11.63 [248] 11.36 [248] 11.13 [249] 10.56 [249] 10.16 [250] 9.97 [251]
33Decrease2.svg 1 Astellas Pharma Flag of Japan.svg  JPN TYO : 4503 10.54 [252] 10.87 [253] 10.08 [254] 10.85 [255] 11.29 [255] 12.27 [256] 12.0712.6311.48
34Decrease2.svg 1 Daiichi Sankyo Flag of Japan.svg  JPN TYO : 4568 10.52 [257] 8.40 [258] 6.87 [259] 6.33 [260] 6.45 [261] 6.11 [262] 6.31 [263] 6.28 [264] 6.48 [265]

See also

References

  1. ↑ "Johnson & Johnson Reports Q4 and Full-Year 2024 Results" (PDF).
  2. 1 2 "Johnson & Johnson Reports Q4 and Full-Year 2023 Results".
  3. 1 2 Johnson & Johnson Reports Q4 and Full-Year 2021 Results (Report). Johnson & Johnson. 25 January 2022.
  4. ↑ "Johnson & Johnson Reports 2019 Fourth-Quarter And Full Year Results". BioSpace. Retrieved 24 December 2022.
  5. ↑ "Johnson & Johnson Reports 2018 Fourth-Quarter Results". Content Lab - U.S.
  6. ↑ "Johnson & Johnson Reports 2017 Fourth-Quarter Results: - Johnson & Johnson". www.jnj.com.
  7. ↑ "Johnson & Johnson Reports 2016 Fourth-Quarter Results - Johnson & Johnson". www.jnj.com.
  8. ↑ "Johnson & Johnson Reports 2015 Fourth-Quarter Results". Archived from the original on 2016-02-11. Retrieved 2018-01-28.
  9. ↑ "Annual Results Announcement for the year ended 31 December 2023" (PDF).
  10. 1 2 "Annual Results Announcement for the year ended 31 December 2022" (PDF).
  11. ↑ All For Health Health For All: Annual Report 2020 (PDF) (Report). Sinopharm Group Co. Ltd. 2020.
  12. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-06-27. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  13. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-06. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  14. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  15. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  16. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2021-02-04. Retrieved 2020-04-30.{{cite web}}: CS1 maint: archived copy as title (link)
  17. ↑ "Roche 2024 results" (PDF).
  18. ↑ "Roche Finance Report 2023" (PDF).
  19. ↑ "Roche Finance Report 2022" (PDF).
  20. 1 2 "[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021". Roche.
  21. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-01-31. Retrieved 2020-01-31.{{cite web}}: CS1 maint: archived copy as title (link)
  22. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-07. Retrieved 2019-02-06.{{cite web}}: CS1 maint: archived copy as title (link)
  23. ↑ "Roche reports good results in 2017". www.roche.com.
  24. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  25. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2017-01-10. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  26. ↑ "Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results".
  27. ↑ "Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results" (PDF).
  28. ↑ "Merck Announces Fourth-Quarter and Full-Year 2022 Financial Results".
  29. 1 2 "Merck Announces Fourth-Quarter and Full-Year 2021 Financial Results".
  30. ↑ "Merck Announces Fourth-Quarter and Full-Year 2019 Financial Results".
  31. ↑ "Merck Announces Fourth-Quarter and Full-Year 2018 Financial Results". BioSpace.
  32. ↑ LaVito, Angelica (2 February 2018). "Merck posts mixed fourth-quarter results as Keytruda sales skyrocket". CNBC .
  33. ↑ Merck & Co., Inc US Securities and Exchange Office
  34. ↑ Merck & Co., Inc US Securities and Exchange Office
  35. 1 2 "Pfizer Reports Strong Full-Year 2024 Results" (PDF).
  36. ↑ "Pfizer Reports Record Full-Year 2022 Results" (PDF).
  37. ↑ Pfizer Reports Fourth-Quarter and Full-Year 2021 Results (PDF) (Report). Pfizer. 2021.
  38. 1 2 3 Annual report Pfizer
  39. ↑ Pfizer Reports Fourth-Quarter and Full-Year 2017 Results Provides 2018 Financial Guidance (PDF) (Report). Pfizer. 30 January 2018.
  40. ↑ Appendix A: 2016 Financial Report (PDF) (Report). Pfizer Inc. and Subsidiary Companies. 2016.
  41. ↑ 2015 Financial Report (PDF) (Report). Pfizer Inc. and Subsidiary Companies. 2015.
  42. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2024 Financial Results".
  43. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Results".
  44. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2022 Financial Results".
  45. 1 2 "AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results". North Chicago, Ill.: Abbvie. 2 February 2022. Retrieved 2022-09-26.
  46. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2019 Financial Results".
  47. ↑ "AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results - AbbVie News Center". news.abbvie.com.
  48. ↑ "Financial Release - AbbVie". investors.abbvie.com.
  49. ↑ "Financial Release - AbbVie". investors.abbvie.com.
  50. ↑ "Financial Release - AbbVie". investors.abbvie.com.
  51. ↑ "Bayer Annual Report 2023" (PDF).
  52. ↑ "Bayer Annual Report 2022" (PDF).
  53. ↑ Bayer Annual Report 2021 (PDF) (Report). Bayer. 2021.
  54. ↑ "Bayer Annual report 2020" (PDF).
  55. ↑ "Bayer Annual Report 2019" (PDF).
  56. ↑ "Bayer Annual Report 2018". www.annualreport2018.bayer.com.
  57. ↑ "Bayer Annual Report 2017" (PDF).
  58. ↑ "Bayer Annual Report 2016" (PDF).
  59. ↑ "Bayer Annual Report 2015" (PDF).
  60. ↑ "Full Year and Q4 2024 results" (PDF). AstraZeneca.
  61. ↑ "Full year and Q4 2023 results" (PDF). AstraZeneca.
  62. ↑ "Full year and Q4 2022 results" (PDF). AstraZeneca.
  63. ↑ "Full year and Q4 2021 results" (PDF). AstraZeneca.
  64. ↑ "Full-year 2020 results" (PDF). AstraZeneca.
  65. ↑ "Full-year and Q4 2019 results" (PDF). AstraZeneca.
  66. ↑ "Full-year and Q4 2018 results" (PDF). AstraZeneca.
  67. ↑ "Full-Year 2017 Results" (PDF). AstraZeneca.
  68. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-03. Retrieved 2018-02-02.{{cite web}}: CS1 maint: archived copy as title (link)
  69. ↑ "Full-Year and Q4 2015 Results". www.astrazeneca.com.
  70. ↑ "Novartis continues strong momentum of sales growth with margin expansion, reaches key innovation milestones in 2024" (PDF).
  71. ↑ "Novartis Financial Results Q4 2023" (PDF).
  72. ↑ "Novartis Financial Results Q4 2022" (PDF).
  73. 1 2 Media release 2021 Novartis
  74. ↑ Media release 2019 Novartis
  75. ↑ Media release 2018 Novartis
  76. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-01-29. Retrieved 2018-01-28.{{cite web}}: CS1 maint: archived copy as title (link)
  77. ↑ Media release 2016 Novartis
  78. ↑ Media release 2015 Novartis
  79. ↑ "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2024".
  80. ↑ "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023" (PDF).
  81. ↑ "Bristol Myers Squibb Q4 2022 Results" (PDF).
  82. 1 2 "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021" (PDF) (Press release). New York, U.S.: Bristol Myers Squibb. 4 February 2022. Retrieved 2022-09-26.
  83. ↑ https://www.biospace.com/article/releases/bristol-myers-squibb-reports-fourth-quarter-and-full-year-financial-results-for-2019/?s=79 [ dead link ]
  84. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results - BMS Newsroom". news.bms.com.
  85. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year Financial Results". investors.bms.com.
  86. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results - BMS Newsroom". news.bms.com.
  87. ↑ "Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results - BMS Newsroom". news.bms.com.
  88. ↑ "Lilly reports full Q4 2024 financial results".
  89. ↑ "Lilly Reports Strong Fourth-Quarter 2023 Financial Results".
  90. ↑ "Lilly Reports Fourth-Quarter 2022 Financial Results".
  91. ↑ "Lilly 2021 Business Results". Lilly.
  92. ↑ "Lilly 2020 Business Results". Lilly.
  93. ↑ "Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition".
  94. ↑ "Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology". BioSpace.
  95. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  96. ↑ "Lilly Reports Fourth-Quarter and Full-Year 2016 Results (NYSE:LLY)". investor.lilly.com.
  97. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2018-02-02. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  98. ↑ "Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025" (PDF).
  99. ↑ "Sanofi Delivers Solid Sales and Business EPS Growth".
  100. ↑ "Sanofi Form 20-F 2022" (PDF).
  101. ↑ "Sanofi Form 20-F 2021" (PDF).
  102. ↑ "Sanofi Form 20-F 2020" (PDF).
  103. ↑ "Sanofi Form 20-F 2019" (PDF).
  104. ↑ "Sanofi Form 20-F 2018" (PDF).
  105. ↑ "Sanofi Form 20-F 2017" (PDF).
  106. ↑ "Sanofi Form 20-F 2016" (PDF).
  107. ↑ "Sanofi Form 20-F 2015" (PDF).
  108. ↑ "Abbott Reports Fourth-Quarter and Full-Year 2024 Results".
  109. ↑ "Abbott reports fourth-quarter and full-year 2023 results".
  110. ↑ "Abbott reports fourth-quarter and full-year 2022 results".
  111. ↑ "Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast".
  112. ↑ Abbott 2020 Annual Report (Report). Abbott. 2020.
  113. ↑ "Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020".
  114. ↑ "Abbott Reports 2018 Results and Issues Strong Forecast for 2019". BioSpace.
  115. ↑ Abbott. "Abbott Reports Fourth-Quarter 2017 Results". www.prnewswire.com.
  116. ↑ Abbott. "Abbott Reports Fourth-Quarter 2016 Results". www.prnewswire.com.
  117. ↑ "Abbott Reports Fourth-Quarter 2015 Results".
  118. ↑ "Novo Nordisk Annual Report 2024" (PDF).
  119. ↑ "Novo Nordisk's sales increased by 31% in 2023".
  120. ↑ "Novo Nordisk Financial report for the period 1 January 2022 to 31 December 2022".
  121. 1 2 Novo Nordisk Annual Report 2021 (PDF) (Report). Novo Nordisk. 2021.
  122. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2020-09-23. Retrieved 2020-02-12.{{cite web}}: CS1 maint: archived copy as title (link)
  123. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2019-02-22. Retrieved 2019-02-21.{{cite web}}: CS1 maint: archived copy as title (link)
  124. ↑ "News details". www.novonordisk.com. Archived from the original on 2018-02-02. Retrieved 2018-02-01.
  125. ↑ "Archived copy" (PDF). Archived from the original (PDF) on 2017-03-22. Retrieved 2018-02-01.{{cite web}}: CS1 maint: archived copy as title (link)
  126. ↑ Transcripts, SA (3 February 2016). "Novo Nordisk's (NVO) CEO Lars Rebien Sorensen on Q4 2015 Results - Earnings Call Transcript".
  127. ↑ "GSK Full-year and fourth quarter 2024" (PDF).
  128. ↑ "GSK Full-year and Fourth Quarter 2023" (PDF).
  129. ↑ "GSK Full-Year and Fourth Quarter 2022" (PDF).
  130. ↑ "Income statement: Year ended 31 December 2021" (PDF).
  131. ↑ GSK Annual Report 2020 (PDF) (Report). GSK. 2020.
  132. ↑ "Full year and fourth quarter 2019" (PDF) (Press release). London, U.K.: GSK. 5 February 2020. Retrieved 2022-09-26.
  133. ↑ "GSK delivers sales, earnings and cash flow growth in 2018 - GSK". www.gsk.com.
  134. ↑ "Full year and fourth quarter 2017" (PDF) (Press release). London, U.K.: GSK. 7 February 2018. Retrieved 2022-09-26.
  135. ↑ GSK Annual Report 2016 (PDF) (Report). GSK. 2016.
  136. ↑ GSK Annual Report 2015 (PDF) (Report). GSK. 2015.
  137. ↑ "Shanghai Pharmaceuticals 2023 Annual Report" (PDF).
  138. ↑ "Shanghai Pharmaceuticals 2022 Annual Results Announcement" (PDF).
  139. 1 2 3 4 5 2021 Annual Results Announcement (PDF) (Report). Shanghai Pharmaceuticals.
  140. 1 2 2017 Annual Report (PDF) (Report). Shanghai Pharmaceuticals.
  141. ↑ "Takeda 2024 Annual Integrated Report" (PDF).
  142. ↑ "Takeda quarterly financial report for the year ended March 31, 2023" (PDF).
  143. ↑ "Takeda quarterly financial report" (PDF). Retrieved June 30, 2022.
  144. ↑ Takeda Quarterly Financial Report (PDF) (Report). Takeda. 31 March 2021.
  145. ↑ "Takeda Accelerates Transformation: Solid FY2019 Results, Confidence in FY2020 Growth Momentum".
  146. ↑ "Takeda Reports FY2018 Full Year Results and Issues FY2019 Guidance".
  147. ↑ "Takeda reports FY2017 full year results and issues FY2018 guidance". www.takeda.com.
  148. ↑ "Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report" (PDF).
  149. ↑ "Amgen Reports Fourth Quarter and Full Year 2024 Financial Results".
  150. ↑ "Amgen Reports Fourth Quarter and Full Year 2023 Financial Results".
  151. ↑ "Amgen Reports Fourth Quarter and Full Year 2022 Financial Results".
  152. ↑ Amgen Reports Fourth Quarter and Full Year 2021: Financial Results (Report). Amgen. 7 February 2022.
  153. ↑ "2020 Letter to Shareholders". Amgen.
  154. ↑ "Amgen Reports Fourth Quarter and Full Year 2019 Financial Results".
  155. ↑ "Amgen - Investors - Press Release". investors.amgen.com.
  156. ↑ "Amgen Reports Fourth Quarter And Full Year 2017 Financial Results". www.amgen.com.
  157. ↑ Amgen - Investors - Press Release
  158. ↑ Amgen - Investors - Press Release [ dead link ]
  159. ↑ "Boehringer Ingelheim Financial Highlights 2023".
  160. ↑ "Boehringer Ingelheim Financial Report 2022" (PDF).
  161. ↑ "Boehringer Ingelheim Summary Report 2021" (PDF).
  162. ↑ "Boehringer Ingelheim Annual Report 2020" (PDF).
  163. ↑ "Boehringer Ingelheim Annual Report 2019" (PDF).
  164. ↑ "Boehringer Ingelheim Annual Report 2018" (PDF).
  165. 1 2 3 "Boehringer Ingelheim Annual Report 2017" (PDF).
  166. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2024 Financial Results" (PDF).
  167. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2023 Financial Results".
  168. 1 2 "Gilead Sciences Announces Fourth Quarter and Full Year 2022 Financial Results" (PDF).
  169. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2020 Financial Results" (PDF).
  170. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2019 Financial Results".
  171. ↑ "Gilead Sciences Announces Fourth Quarter and Full Year 2018 Financial Results". BioSpace.
  172. 1 2 3 "Investor Overview". Gilead Sciences.
  173. ↑ "Siemens Healthineers achieves targets for 2024 fiscal year with strong fourth quarter" (PDF).
  174. ↑ "Siemens Healthineers closes fiscal year with strong fourth quarter" (PDF).
  175. ↑ "Siemens Healthineers Annual Report 2022" (PDF).
  176. 1 2 Siemens Healthineers Annual Report 2021 (PDF) (Report). Siemens Healthineers. 2021.
  177. ↑ Siemens Healthineers Annual Report 2019 (PDF) (Report). Siemens Healthineers. 2019.
  178. ↑ Siemens Healthineers Annual Report 2018 (PDF) (Report). Siemens Healthineers. 2018.
  179. 1 2 3 Combined Financial Statements for the fiscal years ended September 30, 2017, 2016 and 2015 (PDF) (Report). Siemens Healthineers. 2018.
  180. ↑ "Merck Group Annual Report 2023" (PDF).
  181. ↑ "Merck Group Annual Report 2022" (PDF).
  182. ↑ Merck Annual Report 2021 (PDF) (Report). Merck. 2021.
  183. ↑ Merck Annual Report 2020 (PDF) (Report). Merck. 2020.
  184. ↑ Merck Annual Report 2019 (PDF) (Report). Merck. 2019.
  185. ↑ "Merck Group Annual Report 2018" (PDF).
  186. ↑ "Merck Group Annual Report 2017" (PDF).
  187. ↑ "Merck Group Annual Report 2016" (PDF).
  188. ↑ "Merck Group Annual Report 2015" (PDF).
  189. ↑ "Jointown Pharmaceutical Group Annual Report 2023" (PDF).
  190. ↑ "Google Finance: Jointown Pharmaceutical Group Co Ltd".
  191. ↑ CSR Report 2021 (PDF) (Report). Jointown Pharmaceutical Group.
  192. ↑ CSR Report 2020 (PDF) (Report). Jointown Pharmaceutical Group.
  193. ↑ CSR Report 2019 (PDF) (Report). Jointown Pharmaceutical Group.
  194. ↑ CSR Report 2018 (PDF) (Report). Jointown Pharmaceutical Group.
  195. ↑ CSR Report 2017 (PDF) (Report). Jointown Pharmaceutical Group.
  196. ↑ CSR Report 2016 (PDF) (Report). Jointown Pharmaceutical Group.
  197. ↑ CSR Report 2015 (PDF) (Report). Jointown Pharmaceutical Group.
  198. ↑ "GE HealthCare reports fourth quarter and full year 2024 financial results".
  199. ↑ "GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results".
  200. ↑ "GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results".
  201. ↑ "GE fourth quarter & full year 2021 performance: Financial results & company highlights" (PDF). GE.
  202. ↑ GE 2020 Annual Report (PDF) (Report). GE. 2020.
  203. 1 2 3 4 5 "General Electric Healthcare segment revenue 2008-2020".
  204. ↑ "Teva Delivers Second Consecutive Year of Growth; Announces Strong Financial Results in Fourth Quarter and Full Year 2024, Led by Generics Performance and Innovative Portfolio Growth".
  205. ↑ "Teva Reports Growth in Fourth Quarter and Full Year 2023".
  206. ↑ "Teva Reports Fourth Quarter and Full Year 2022 Financial Results".
  207. ↑ "Teva Reports Fourth Quarter and Full Year 2021 Financial Results" (PDF). Tel Aviv: Teva. 9 February 2022. Retrieved 2022-09-26.
  208. ↑ TEVA
  209. ↑ "Teva Reports Fourth Quarter and Full Year 2019 Financial Results".
  210. ↑ TEVA
  211. ↑ "Teva Reports 2017 Full Year and Fourth Quarter Financial Results". 8 February 2018.
  212. ↑ "Teva Reports Full Year and Fourth Quarter 2016 Financial Results". Archived from the original on 2018-02-03. Retrieved 2018-02-08.
  213. ↑ "Teva Reports Full Year 2015 and Fourth Quarter Financial Results". Archived from the original on 2018-09-15. Retrieved 2018-02-08.
  214. ↑ "Kenvue Reports Full Year and Fourth Quarter 2024 Results".
  215. 1 2 "Kenvue Reports Full Year and Fourth Quarter 2023 Results".
  216. ↑ "Viatris Reports Fourth Quarter and Full Year 2024 Financial Results".
  217. ↑ "Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results".
  218. 1 2 "Viatris Reports Strong Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance".
  219. ↑ "Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results".
  220. ↑ "Regeneron Reports Fourth Quarter and Full Year 2024 Financial and Operating Results".
  221. ↑ "Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results".
  222. ↑ "Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results".
  223. 1 2 Regeneron Reports Fourth Quarter and Full Year 2021 Financial and Operating Results (Report). Regeneron. 4 February 2022.
  224. 1 2 3 "Regeneron Form 10-K 2019".
  225. ↑ "Regeneron Form 10-K 2016".
  226. ↑ "Regeneron Form 10-K 2015".
  227. ↑ "Haleon 2024 Full year results" (PDF).
  228. ↑ "Haleon 2023 Full Year Results" (PDF).
  229. ↑ "Haleon 2022 Full Year Results" (PDF).
  230. ↑ "Haleon Prospetus" (PDF).
  231. ↑ "Integrated Report 2024" (PDF). Otsuka Holdings.
  232. ↑ "Consolidated Financial Results for the Fiscal Year Ended December 31, 2022" (PDF). Otsuka Holdings.
  233. 1 2 3 4 5 6 7 "Otsuka Integrated Report 2021" (PDF).
  234. ↑ "Vertex Reports Fourth Quarter and Full Year 2024 Financial Results".
  235. ↑ "Vertex Reports Fourth Quarter and Full Year 2023 Financial Results".
  236. ↑ "Vertex Reports Fourth Quarter and Full Year 2022 Financial Results".
  237. ↑ "Vertex Reports Fourth Quarter 2021 and Full Year Financial Results".
  238. ↑ "Vertex Reports Full-Year and Fourth-Quarter 2020 Financial Results".
  239. ↑ "Vertex Reports Full-Year and Fourth-Quarter 2019 Financial Results".
  240. ↑ "Vertex Reports Full-Year and Fourth-Quarter 2018 Financial Results".
  241. ↑ "Vertex Reports Full-Year and Fourth-Quarter 2017 Financial Results".
  242. ↑ "Vertex Reports Full-Year and Fourth-Quarter 2016 Financial Results".
  243. ↑ "Vertex Reports Full-Year and Fourth Quarter 2015 Financial Results".
  244. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2024 Results".
  245. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2023 Results".
  246. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2022 Results".
  247. ↑ "Baxter Reports Fourth-Quarter and Full-Year 2021 Results".
  248. 1 2 Statements of Income (Unaudited) Baxter International
  249. 1 2 Statements of Income (Unaudited) Baxter International
  250. ↑ Statements of Income (Unaudited) Baxter International
  251. ↑ Statements of Income (Unaudited) Baxter International
  252. ↑ "Financial Results of Astellas for Fiscal Year 2023" (PDF).
  253. ↑ "Financial Results of Astellas for Fiscal Year 2022" (PDF).
  254. ↑ "Financial Results of Astellas for Fiscal Year 2021" (PDF).
  255. 1 2 For the Year Ended March 31, 2021 Annual Report 2021 (PDF) (Report). Astellas. 31 March 2020.
  256. ↑ "Astellas Pharma Inc. Annual Report 2018" (PDF). www.astellas.com.
  257. ↑ "Daiichi Sankyo FY2023 Financial Results" (PDF).
  258. ↑ "Daiichi Sankyo FY2022 Financial Results" (PDF).
  259. ↑ "Daiichi Sankyo FY2021 Financial Results" (PDF).
  260. ↑ "Daiichi Sankyo FY2020 Financial Results" (PDF).
  261. ↑ "Daiichi Sankyo FY2019 Financial Results" (PDF).
  262. ↑ "Daiichi Sankyo FY2018 Financial Results" (PDF).
  263. ↑ "Daiichi Sankyo FY2017 Financial Results" (PDF).
  264. ↑ "Daiichi Sankyo FY2016 Financial Results" (PDF).
  265. ↑ "Daiichi Sankyo FY2015 Financial Results" (PDF).
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.